CoChat
Sign Up
Cited by 42

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

A rapid flat gel isoelectric focusing method for the determination of apolipoprotein E phenotypes and its application

Eto, M., Watanabe, K., Ishii, K.·1985·Clinica Chimica Acta
DOI 10.1016/0009-8981(85)90269-4
Open this paper in CoChat — free account

Abstract

A rapid flat gel isoelectric focusing method has been developed for the determination of apolipoprotein E phenotypes. Isoelectric focusing in 5% polyacrylamide flat gel with 8 mol/l urea and 2.8% pharmalyte (pH 4-6.5) was carried out at 3,000 V and 4 degrees C for 1 h under a constant power of 30 W. The separation of apolipoprotein E isoproteins was good and the isoelectric points were determined. Using this method, the apolipoprotein E phenotype frequency was examined in the Japanese population, and a higher frequency of phenotype E3/3 and a lower frequency of phenotype E3/2 were found in Japanese than those reported for the German, American or English population. In our focusing system the cut-off point of apolipoprotein E2/E3 ratio between the phenotype E3/3 and E3/2 was assumed to be approximately 0.9. These results indicate that this method may be useful for the determination of apolipoprotein E phenotypes.

Overview

Integrity signals

Registry

Crossref · 10.1016/0009-8981(85)90269-4

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 18

  1. Shelburne, 1980, Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat, J Clin Invest, 65, 652, 10.1172/JCI109710 · DOI
  2. Sherrill, 1980, Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor, J Biol Chem, 255, 1804, 10.1016/S0021-9258(19)85951-3 · DOI
  3. Innerarity, 1978, Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins, Biochemistry, 17, 1440, 10.1021/bi00601a013 · DOI · Paper page
  4. Utermann, 1975, Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins, FEBS Lett, 56, 352, 10.1016/0014-5793(75)81125-2 · DOI · Paper page
  5. Utermann, 1977, Polymorphism of apolipoprotein E and occurrence of dysbetali-poproteinemia in man, Nature (London), 269, 604, 10.1038/269604a0 · DOI · Paper page
  6. Pagnan, 1977, Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetali-poproteinemia, J Lipid Res, 18, 613, 10.1016/S0022-2275(20)41603-7 · DOI
  7. Weisgraber, 1982, Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site, J Biol Chem, 257, 2518, 10.1016/S0021-9258(18)34954-8 · DOI · Paper page
  8. Havel, 1982, Familial dysbetalipoproteinemia, new aspects of pathogenesis and diagnosis, Med Clin North Am, 66, 441, 10.1016/S0025-7125(16)31429-8 · DOI
  9. Gumming, 1984, Polymorphism at the apoprotein-E locus in relation to risk of coronary disease, Clin Genet, 25, 310, 10.1111/j.1399-0004.1984.tb01995.x · DOI
  10. Ghiselli, 1982, Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia, J Clin Invest, 70, 474, 10.1172/JCI110638 · DOI
  11. Kameda, 1984, Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan, Atherosclerosis, 51, 241, 10.1016/0021-9150(84)90171-0 · DOI
  12. Utermann, 1978, Polymorphism of apolipoprotein E. 1. Methodological aspects and diagnosis of hyperlipoproteinemia type III without ultracentrifugation, Clin Genet, 14, 351, 10.1111/j.1399-0004.1978.tb02101.x · DOI
  13. Warnick, 1979, Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3, Clin Chem, 25, 279, 10.1093/clinchem/25.2.279 · DOI · Paper page
  14. Douste-Blazy, 1982, Increased frequency of apo E-ND phenotype and hyperapobetalipoproteinemia in normolipidemic subjects with xanthelasmas of the eyelids, Ann Int Med, 96, 164, 10.7326/0003-4819-96-2-164 · DOI
  15. Weidmann, 1979, Type III hyperlipoproteinemia: development of a VLDL apo E gel isoelectric focusing technique and application in family studies, J Lab Clin Med, 93, 549
  16. Havel, 1955, The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum, J Clin Invest, 34, 1345, 10.1172/JCI103182 · DOI
  17. Yamamura, 1984, A new isoform of apolipoprotein E-apo E-5-associated with hyperlipidemia and atherosclerosis, Atherosclerosis, 50, 159, 10.1016/0021-9150(84)90019-4 · DOI · Paper page
  18. Utermann, 1980, Genetics of the apolipoprotein E system in man, Am J Hum Genet, 32, 339

Cited by

Sorted by citations

Metadata

Authors
Eto, M., Watanabe, K., & Ishii, K.
Venue
Clinica Chimica Acta
Publisher
Elsevier BV
Published
1985-06
Volume
149
Issue
1
Pages
21-28
ISSN
0009-8981
DOI
10.1016/0009-8981(85)90269-4
Cited by
42
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review